Effect of Evidence-Based Skin Care and Hydrocolloid Dressing in the Prevention of Nasogastric-Related Pressure Injury
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04682925|
Recruitment Status : Recruiting
First Posted : December 24, 2020
Last Update Posted : August 5, 2022
|Condition or disease||Intervention/treatment||Phase|
|Medical Device Site Injury Nasogastric Tube Pressure Injury||Other: skin care arm of where evidence-based practices in the implementation guide Device: hydrocolloid (Convatec Granuflex-extra thin) dressing Other: control||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||102 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Prospective Randomized Controlled Clinical Trial|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Effect of Evidence-Based Skin Care and Hydrocolloid Dressing in the Prevention of Nasogastric-Related Pressure Injury: A Randomized Controlled Trial|
|Actual Study Start Date :||January 15, 2021|
|Actual Primary Completion Date :||May 15, 2022|
|Estimated Study Completion Date :||December 15, 2022|
Experimental: skin care arm of where evidence-based practices in the implementation guide
Participants in this arm will be given evidence-based skin care interventions, which are included in the guidelines to prevent medical device-related pressure injuries, and are implemented by the researcher nurse. After the nasogastric tube is inserted by the patient's physician.
Other: skin care arm of where evidence-based practices in the implementation guide
Experimental: hydrocolloid (Convatec Granuflex-extra thin) dressing
Patients in this arm will be applied a translucent hydrocolloid cover, which is compatible with the sensitive skin structure, can be applied to all body surfaces and nasal mucosa, and allows the underlying mucosa and skin to be observed after the nasogastric tube is inserted by the patient's physician. This cover will be applied to the nasal mucosa and nasal wing under the nasogastric tube.
Device: hydrocolloid (Convatec Granuflex-extra thin) dressing
The nasal skin of the patients and the surrounding skin will be cleaned with a pH-compatible cleaner, dried and a new hydrocolloid cover will be applied once a day. All these care interventions applied to the hydrocolloid dressing arm will be applied together with the physician and nurse responsible for the treatment and care of the patient.
Participants in the control group will be given no intervention , these patients will receive the routine clinical care(dressing change and nasal skin cleaning once a day) applied in the intensive care unit.
In routine care, the skin under the nasogastric tube is evaluated once a day for redness and wound formation by the nurse responsible for the patient's care and is cleaned and dried with appropriate cleaners.
- rate of pressure injury from nasogastric tube [ Time Frame: Each participant will be followed for 18 days ]Pressure injury originating from nasogastric tube will be evaluated with the reliable international NPUAP / EPUAP Pressure Ulcer Classification System. In the literature, pressure injuries originating from nasogastric tube are reported to develop in 11± 5 days. Accordingly, patients will be cared for and followed up for 18 days. The day the pressure injury develops will be recorded in each group.
- The most effective intervention in preventing pressure injuries caused by nasogastric tube [ Time Frame: Each participant will be followed for 18 days ]It recommends evidence-based practices, twice-daily skin care or daily prophylactic dressing to prevent nasogastric tube-induced pressure injuries. The most effective method to prevent pressure injury will be revealed. Pressure injury originating from nasogastric tube will be evaluated with the reliable international NPUAP / EPUAP Pressure Ulcer Classification System.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04682925
|Contact: MAİDE YEŞİLYURT, MScemail@example.com|
|Contact: SERPİL YÜKSEL, PhDfirstname.lastname@example.org|
|Necmettin Erbakan University||Recruiting|
|Konya, Turkey, 42080|
|Contact: MAİDE YEŞİLYURT, MSc +905378777581 email@example.com|
|Principal Investigator: SERPİL YÜKSEL, PhD|
|Sub-Investigator: ALPER YOSUNKAYA, PhD|
|Sub-Investigator: MAİDE YEŞİLYURT, MSc|
|Principal Investigator:||SERPİL YÜKSEL, PhD||Necmettin Erbakan University|
|Study Director:||ALPER YOSUNKAYA, PhD||Necmettin Erbakan University|
|Study Director:||MAİDE YEŞİLYURT, MSc||Necmettin Erbakan University|